These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38233012)

  • 21. Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
    Ma L; Waldmann E; Ooi EMM; Chan DC; Barrett HPR; Watts GF; Parhofer KG
    Eur J Clin Invest; 2019 Feb; 49(2):e13053. PubMed ID: 30447089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between "LDL-C", estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide.
    Viney NJ; Yeang C; Yang X; Xia S; Witztum JL; Tsimikas S
    J Clin Lipidol; 2018; 12(3):702-710. PubMed ID: 29574075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of genetically predicted lipid traits and lipid-modifying targets with heart failure.
    Xiao J; Ji J; Zhang N; Yang X; Chen K; Chen L; Huang W
    Eur J Prev Cardiol; 2023 Mar; 30(4):358-366. PubMed ID: 36520639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study.
    Ioannidou A; Watts EL; Perez-Cornago A; Platz EA; Mills IG; Key TJ; Travis RC; ; Tsilidis KK; Zuber V
    PLoS Med; 2022 Jan; 19(1):e1003859. PubMed ID: 35085228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study.
    Jiang Q; Qin D; Yang L; Lin Y; Zhai L; Zhang Y; Yang G; Wang K; Tong D; Li X; Chen Z; Huang K; Yu T; Xiang X; Cui C; Cai C; Shi J; Li M; Chen M
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1569-1578. PubMed ID: 33814236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
    Mohammadi-Shemirani P; Chong M; Narula S; Perrot N; Conen D; Roberts JD; Thériault S; Bossé Y; Lanktree MB; Pigeyre M; Paré G
    J Am Coll Cardiol; 2022 Apr; 79(16):1579-1590. PubMed ID: 35450575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.
    Enkhmaa B; Anuurad E; Zhang W; Berglund L
    Atherosclerosis; 2014 Jul; 235(1):223-9. PubMed ID: 24859635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a).
    Kronenberg F
    Handb Exp Pharmacol; 2022; 270():201-232. PubMed ID: 34196811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
    Clarke R; Hammami I; Sherliker P; Valdes-Marquez E; Watkins H; Hill M; Yang X; Tsimikas S; Hopewell JC;
    Atherosclerosis; 2022 Aug; 354():15-22. PubMed ID: 35803063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Rikhi R; Hammoud A; Ashburn N; Snavely AC; Michos ED; Chevli P; Tsai MY; Herrington D; Shapiro MD
    Atherosclerosis; 2022 Dec; 363():102-108. PubMed ID: 36253168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
    Ballantyne CM; Raichlen JS; Cain VA
    J Am Coll Cardiol; 2008 Aug; 52(8):626-32. PubMed ID: 18702965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study.
    Zheng KH; Arsenault BJ; Kaiser Y; Khaw KT; Wareham NJ; Stroes ESG; Boekholdt SM
    J Am Heart Assoc; 2019 Aug; 8(16):e013020. PubMed ID: 31407609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein Characteristics and Incident Coronary Heart Disease: Prospective Cohort of Nearly 90 000 Individuals in UK Biobank.
    Jin D; Trichia E; Islam N; Bešević J; Lewington S; Lacey B
    J Am Heart Assoc; 2023 Oct; 12(20):e029552. PubMed ID: 37815053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.
    Steffen BT; Guan W; Remaley AT; Paramsothy P; Heckbert SR; McClelland RL; Greenland P; Michos ED; Tsai MY
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):448-54. PubMed ID: 25477346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).
    Albers JJ; Slee A; O'Brien KD; Robinson JG; Kashyap ML; Kwiterovich PO; Xu P; Marcovina SM
    J Am Coll Cardiol; 2013 Oct; 62(17):1575-9. PubMed ID: 23973688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
    Marston NA; Giugliano RP; Melloni GEM; Park JG; Morrill V; Blazing MA; Ference B; Stein E; Stroes ES; Braunwald E; Ellinor PT; Lubitz SA; Ruff CT; Sabatine MS
    JAMA Cardiol; 2022 Mar; 7(3):250-256. PubMed ID: 34773460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordance between apolipoprotein B and low-density lipoprotein particle number is associated with insulin resistance in clinical practice.
    Varvel SA; Dayspring TD; Edmonds Y; Thiselton DL; Ghaedi L; Voros S; McConnell JP; Sasinowski M; Dall T; Warnick GR
    J Clin Lipidol; 2015; 9(2):247-55. PubMed ID: 25911082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.